Literature DB >> 26970431

Drug allergies documented in electronic health records of a large healthcare system.

L Zhou1,2,3, N Dhopeshwarkar1, K G Blumenthal4, F Goss5, M Topaz1,3, S P Slight1,6, D W Bates1,3.   

Abstract

BACKGROUND: The prevalence of drug allergies documented in electronic health records (EHRs) of large patient populations is understudied.
OBJECTIVE: We aimed to describe the prevalence of common drug allergies and patient characteristics documented in EHRs of a large healthcare network over the last two decades.
METHODS: Drug allergy data were obtained from EHRs of patients who visited two large tertiary care hospitals in Boston from 1990 to 2013. The prevalence of each drug and drug class was calculated and compared by sex and race/ethnicity. The number of allergies per patient was calculated and the frequency of patients having 1, 2, 3…, or 10+ drug allergies was reported. We also conducted a trend analysis by comparing the proportion of each allergy to the total number of drug allergies over time.
RESULTS: Among 1 766 328 patients, 35.5% of patients had at least one reported drug allergy with an average of 1.95 drug allergies per patient. The most commonly reported drug allergies in this population were to penicillins (12.8%), sulfonamide antibiotics (7.4%), opiates (6.8%), and nonsteroidal anti-inflammatory drugs (NSAIDs) (3.5%). The relative proportion of allergies to angiotensin-converting enzyme (ACE) inhibitors and HMG CoA reductase inhibitors (statins) have more than doubled since early 2000s. Drug allergies were most prevalent among females and white patients except for NSAIDs, ACE inhibitors, and thiazide diuretics, which were more prevalent in black patients.
CONCLUSION: Females and white patients may be more likely to experience a reaction from common medications. An increase in reported allergies to ACE inhibitors and statins is noteworthy.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  adverse drug event; drug allergy; drug hypersensitivity; electronic health records; safety

Mesh:

Substances:

Year:  2016        PMID: 26970431     DOI: 10.1111/all.12881

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  55 in total

1.  Drug Hypersensitivity Reactions Documented in Electronic Health Records within a Large Health System.

Authors:  Adrian Wong; Diane L Seger; Kenneth H Lai; Foster R Goss; Kimberly G Blumenthal; Li Zhou
Journal:  J Allergy Clin Immunol Pract       Date:  2018-12-01

2.  AllergyMap: An Open Source Corpus of Allergy Mention Normalizations.

Authors:  Amy Y Wang; John D Osborne; Maria I Danila; Andrew M Naidech; David M Liebovitz
Journal:  AMIA Annu Symp Proc       Date:  2021-01-25

3.  The Impact of a Reported Penicillin Allergy on Surgical Site Infection Risk.

Authors:  Kimberly G Blumenthal; Erin E Ryan; Yu Li; Hang Lee; James L Kuhlen; Erica S Shenoy
Journal:  Clin Infect Dis       Date:  2018-01-18       Impact factor: 9.079

4.  Penicillin Allergy Testing Is Cost-Saving: An Economic Evaluation Study.

Authors:  Bernardo Sousa-Pinto; Kimberly G Blumenthal; Eric Macy; Ana Margarida Pereira; Luís Filipe Azevedo; Luís Delgado; João Almeida Fonseca
Journal:  Clin Infect Dis       Date:  2021-03-15       Impact factor: 9.079

5.  High-cost, high-need patients: the impact of reported penicillin allergy.

Authors:  Kimberly G Blumenthal; Nicolas M Oreskovic; Xiaoqing Fu; Fatma M Shebl; Christian M Mancini; Jennifer M Maniates; Rochelle P Walensky
Journal:  Am J Manag Care       Date:  2020-04       Impact factor: 2.229

Review 6.  The 3 Cs of Antibiotic Allergy-Classification, Cross-Reactivity, and Collaboration.

Authors:  Jason A Trubiano; Cosby A Stone; M Lindsay Grayson; Karen Urbancic; Monica A Slavin; Karin A Thursky; Elizabeth J Phillips
Journal:  J Allergy Clin Immunol Pract       Date:  2017-08-23

7.  Multiple drug intolerance syndrome and multiple drug allergy syndrome: Epidemiology and associations with anxiety and depression.

Authors:  K G Blumenthal; Y Li; W W Acker; Y Chang; A Banerji; S Ghaznavi; C A Camargo; L Zhou
Journal:  Allergy       Date:  2018-10       Impact factor: 13.146

Review 8.  Addressing Inpatient Beta-Lactam Allergies: A Multihospital Implementation.

Authors:  Kimberly G Blumenthal; Erica S Shenoy; Anna R Wolfson; David N Berkowitz; Victoria A Carballo; Diana S Balekian; Kathleen A Marquis; Ramy Elshaboury; Ronak G Gandhi; Praveen Meka; David W Kubiak; Jennifer Catella; Barbara B Lambl; Joyce T Hsu; Monique M Freeley; Alana Gruszecki; Paige G Wickner
Journal:  J Allergy Clin Immunol Pract       Date:  2017 May - Jun

9.  Implications of electronic health record transition on drug allergy labels.

Authors:  Christine R F Rukasin; Susanne Henderlight; Terry Bosen; Scott D Nelson; Elizabeth J Phillips
Journal:  J Allergy Clin Immunol Pract       Date:  2019-07-24

10.  How antibiotic allergy labels may be harming our most vulnerable patients.

Authors:  Jason A Trubiano; M Lindsay Grayson; Karin A Thursky; Elizabeth J Phillips; Monica A Slavin
Journal:  Med J Aust       Date:  2018-06-18       Impact factor: 7.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.